Anti-Müllerian hormone as marker of ovarian reserve in patients with long-standing type 1 diabetes

T Filardi, Filardi T, Morano S, S Morano, Tartaglione S, S Tartaglione, Maria Grazia Porpora, M G Porpora, Tiberti C, C Tiberti, Lenzi A, A Lenzi, Angeloni A, A Angeloni, E Anastasi, Anastasi E
Journal of biological regulators and homeostatic agents · 2020 · doi:10.23812/20-365-L · PMID:33179464
other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite+body, 2026-06-13 ⓘ

This study evaluated anti-Müllerian hormone (AMH) as a marker of ovarian reserve in patients with long-standing type 1 diabetes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text ⓘ

This paper evaluated anti-Müllerian hormone (AMH) as a marker of ovarian reserve in patients with long-standing type 1 diabetes, using an observational approach to relate AMH levels to measures of reproductive ovarian reserve. The key finding reported in the study is that AMH can function as an indicator of ovarian reserve in this specific clinical population. A major limitation is that the report is constrained to the type 1 diabetes group and does not establish causal mechanisms for any AMH–ovarian reserve relationship. Relevance to endometriosis: the article includes endometriosis among its listed keywords and is positioned within a corpus of infertility/ovarian-reserve literature that references endometriosis, though the paper’s main focus is AMH in long-standing type 1 diabetes rather than endometriosis itself.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 3,785 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Keywords

AMH;anti-Müllerian hormone;endometriosis;infertility;ovarian reserve;type 1 diabetes;diabetes

References

Supporting Agencies Copyright (c) 2020 T. Filardi, S. Morano, S. Tartaglione, M.G. Porpora, C. Tiberti, A. Lenzi, A. Angeloni, E. Anastasi This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Editor-in-Chief Medical Genetics, University of Torino Medical School, Italy Co-Editor-in-Chief Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy Indexing & Archiving News & Announcements 2026-02-09 Journal of Biological Regulators and Homeostatic Agents (JBRHA, Print ISSN: 0393-974X, Electronic ISSN: 1724-6083) has officially transitioned to China Scientific Research Publishing, taking over publication from Asia Pacific Academy of Science Pte. Ltd. with effect from Vol 40, No 1 (2026). All new submissions should be made via the new journal website at https://journal.csrp-pub.com/index.php/jbrha from February 10, 2026. For any inquiries regarding this transition and the publication of manuscripts being processed, please contact the new publisher at [email protected] or [email protected]. 2025-02-01 In addition to the first issue that has already been published by the original publisher, there will be four more issues released this year, with scheduled publication dates in March, June, September, and December respectively. 2025-01-21 Starting from Volume 39 Issue 2 (2025), the ownership of Journal of Biological Regulators and Homeostatic Agents (ISSN: 0393-974X (P); 1724-6083 (O)) will be transferred from Biolife Sas to Asia Pacific Academy of Science Pte. Ltd. As of 21 January 2025, authors should make submissions to the new journal system and follow the author guidelines. Asia Pacific Academy of Science Pte. Ltd. will take over the publication of manuscripts being processed.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Diabetes Mellitus, Type 1 Ovarian Reserve Anti-Mullerian Hormone Endometriosis Female Humans Infertility, Female

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-13T06:15:24.848197+00:00
pubmed
last seen: 2026-05-13T22:21:36.268089+00:00
unpaywall
last seen: 2026-08-15T06:29:46.044917+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine